NATIONAL CENTER OF BIOPRODUCTS

Trials shown by sponsor

Public title	Date of Registration	State
Biomodulina T - IM - covid-19 - older adult	29/05/2020	Registered
Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis	28/05/2020	Registered
Pharmacovigilance-VALERGEN-Asthma	27/01/2017	Registered
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study	21/12/2020	Registered
Subcutaneous immunotherapy with PROLINEM -Asthma- Adults-Fase I	2013-01-04	Registered
Combined Subcutaneous immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II	2012-04-13	Registered
Sublingual immunotherapy with VALERGEN-Asthma-Children-Phase II	2012-04-02	Registered
Evidence of the clinical efficacy of VALERGEN-DS vaccine in asthmatics.	2010-12-09	Registered
Evidence of the clinical efficacy of VALERGEN-BT vaccine in asthmatics	2010-12-09	Registered
Efficacy of VALERGEN-DP sublingual vaccine in asthmatic adults.	2010-12-09	Registered
Evidence of the clinical efficacy of VALERGEN-DP vaccine in asthmatics	2010-12-09	Registered
Efficacy of VALERGEN-BT sublingual vaccine in asthmatic adults.	2010-12-08	Registered
Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults	2010-12-08	Registered
Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults	2010-12-07	Registered
Efficacy of VALERGEN-DP subcutaneous vaccine in asthmatic adults	2010-12-07	Registered
Efficacy of VALERGEN-DS subcutaneous vaccine in asthmatic adults.	2010-12-07	Registered
BIOMODULINA T in a long-lived population at high risk of COVID-19 infection	19/09/2020	Registered
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II	17/02/2017	Registered
Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III.	15/08/2018	Registered outdated
Efficacy of nasal provocation test with VALERGEN-DP, DS and BT	15/04/2019	Registered outdated

Registered Trials

Registration process

NATIONAL CENTER OF BIOPRODUCTS

About the RPCEC

Useful resources